Novocure Ltd (NASDAQ:NVCR)
| 17.59 Delayed Data As of Sep 21 |  -0.19 / -1.07%Today’s Change | 17.14 Today|||52-Week Range 120.03 | -76.02% Year-to-Date |
Latest NVCR News | Press Releases
| 3 Things About NovoCure That Smart Investors Know Sep 19 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 17.78 |
| Today’s open | 17.45 |
| Day’s range | 17.17 - 17.88 |
| Volume | 60,978 |
| Average volume (3 months) | 1,857,123 |
| Market cap | $2.1B |
Data as of 3:59pm ET, 09/21/2023
Growth & Valuation
| Earnings growth (last year) | -56.73% |
| Earnings growth (this year) | -122.27% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +0.53% |
| P/E ratio | NM |
| Price/Sales | 14.27 |
| Price/Book | 4.60 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TNDMTandem Diabetes Care... | -1.52 | -6.68% |
| ---- | ||
| ---- | ||
| IRTCiRhythm Technologies... | -2.12 | -2.37% |
Data as of 3:59pm ET, 09/21/2023
Financials
| Next reporting date | October 26, 2023 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $537.8M |
| Annual profit (last year) | -$92.5M |
| Net profit margin | -17.20% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters St. Helier, Jersey |
Forecasts
